Electromed, Inc.

ELMD Healthcare Medical Devices

Electromed, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $73.8 million, up 15.3% from fiscal 2025. In the quarter to June 2026, revenue grew 11.6%, EPS grew 57.7% and free cash flow fell 25.2%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

27.42 0.61 −2.18%
Market cap
$232.3M
P/E
20.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
8/9
Altman Z
20.30
Beneish M
−2.20
Dividend safety
n/a

Electromed, Inc. (ELMD) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Electromed, Inc. (ELMD) trades at a P/E ratio of 20.0×. Over the past ten years it has ranged from 7.9× (January 2016) to 138× (January 2015); the current reading is higher than 16% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 30.9× 23.56%
FY2025 25.0× 5.96%
FY2024 23.6× (16.32%)
FY2023 28.2× (18.14%)
FY2022 34.4× (14.61%)
FY2021 40.3× 28.38%
FY2020 31.4× 42.49%
FY2019 22.0× (6.12%)
FY2018 23.5× 14.63%
FY2017 20.5× 43.26%

Quarterly newest first

Period P/E ratio Change
Jun 2026 30.9× 60.91%
Mar 2026 19.2× (29.49%)
Dec 2025 27.2× 7.53%
Sep 2025 25.3× 1.28%
42 more quarters

Against its own ten years

Low 7.9× High 138×
Ten-year median 25.9×
Current reading's percentile 11

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ELMD